HOME >> BIOLOGY >> NEWS
Common properties in the genes implicated in the development of cancer

Two researchers from the University of Navarra, Javier Novo and Jos Luis Vizmanos, have performed a bioinformatic study on the genes which have been implicated in the development of cancer. The research project has been described in an article which will be published shortly in Trends in Genetics, one of the five best journals in the area of "Genetics and Inheritance".

This bioinformatic study has permitted the researchers to identify certain common properties in those genes which are involved in the development of cancer. Dr. Novo explained that "the objective consisted in discovering whether those genes which suffer translocations (breakages) in this disease have any structural or functional characteristics in common".

Concretely, the research project performed by the two scientists of the Department of Genetics at the University of Navarra has provided, for the first time, clear data which support the hypothesis that the most important mechanisms in the development of tumors are those which generate random breakage.

"When a normal cell becomes tumorous, one of the most important changes that it experiences is that its genome becomes unstable, and breaks in various places," explained Dr. Novo. Until now, there have been many examples of this kind of breakage published, "but it was not well known what caused them nor how they were produced; for example, if they were produced at random, or if there was something in the sequence which aided in their appearance in concrete locations."

Database with Genome Regions

The authors of the article published in Trends in Genetics have constructed a data base with all the regions of the genome which break in the various types of tumors. "Over the course of several months, with the help of students from the School of Sciences, we collected from the scientific literature all the breakages which have been described in relation to cancer, we located them in the sequence
'"/>

Contact: Garazi Andonegi
garazi@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
7-Mar-2006


Page: 1 2

Related biology news :

1. Common environmental chemicals in diet affect fetal ovarian development
2. Common cancer gene sends death order to tiny killer
3. Common treatment for methamphetamine overdose may damage brain cells
4. Common genetic variation is linked to substantial risk for heart attack
5. Common fungicide causes long-term changes in mating behavior
6. DNA ends: Common tool, different job
7. Common gene version optimizes thinking -- but with a possible downside
8. Common mechanisms for viral DNA replication
9. Common ancestry of bacterium and plants could be key to an effective new treatment for chlamydia
10. Common cause of heart disease, diabetes may be treatable with malaria drug
11. Commonplace sugar compound silences seizures

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2020)... ... June 24, 2020 , ... eClinical Solutions LLC ... services that accelerate drug development, is collaborating with Karyopharm Therapeutics (Nasdaq: KPTI ... patients with severe COVID-19. This is the first study of an XPO1 inhibitor ...
(Date:6/23/2020)... ... June 22, 2020 , ... The field of quantitation of large molecules ... have dominated this area. However, the use of mass spectrometry in this field has ... the question “How do you choose which approach to use (LBA or MS)?” ...
(Date:6/19/2020)... ... June 16, 2020 , ... The director of stem cell ... if the stem cell medicine and pharmaceutical industries have easier access to stem cell ... starting July 5 of this year, Independence Day weekend in the U.S., Asymmetrex is ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... ... August 11, 2020 , ... The FSHD ... Facioscapulohumeral Muscular Dystrophy Clinical Trial Research Network (FSHD CTRN), with consideration ... is a consortium of academic research centers in the United States and Europe ...
(Date:8/7/2020)... , ... August 06, 2020 , ... ... vaccine industries, announces it has closed on the purchase of greenfield for a ... Conroe, TX and includes over 21 acres in the initial acquisition, with an ...
(Date:7/31/2020)... ... 29, 2020 , ... R3 Stem Cell International is now offering patients the ... stem cells total, patients may choose which extremities they would like treated. , Several ... Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is obtained from a lab ...
(Date:7/31/2020)... ... July 29, 2020 , ... Anomet Products ... three different materials for use with CRM, neurostimulation, vascular, and related devices. , ... meet specific design requirements, performance, and cost criteria; especially where solid wire is ...
Breaking Biology Technology:
Cached News: